First patients enrolled in COHERENT AF IDE clinical trial!

Argá Medtech is pleased to announce that the first patients in the COHERENT AF IDE clinical trial have been treated with the Coherent Sine Burst Electroporation (CSE) System by Dr. Ante Anic at KBC Split, Croatia. The study is designed to test the safety and effectiveness of the CSE System, which features the ONLY sine-wave based pulsed field ablation (PFA) generator and SINGLE stylet-driven, multi-configurable ablation catheter, in patients with paroxysmal and persistent atrial fibrillation. We anticipate additional center starts across the US and Europe in the very near future.

Congratulations to @anteanic, his staff and the entire Argá Medtech team for achieving this important milestone.

CAUTION – This product is limited by U.S. Federal Law to investigational use. Product is not approved globally and may not be available in your market.